John Reynolds

Projects

Projects per year 2014 2018 2019 2020 2024 2028

• 11 Active
• 13 Finished

Projects per year

Search results

• Active

  GLAM study - Genomic Liquid biopsy Analysis for Multiple myeloma

  Spencer, A. (Primary Chief Investigator (PCI)), Mithraprabhu, S. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Wood, E. (Chief Investigator (CI)), Wellard, C. (Chief Investigator (CI)), Bingham, N. (Chief Investigator (CI)), Wong, D. (Chief Investigator (CI)), Irving, A. (Chief Investigator (CI)), Wright, T. (Chief Investigator (CI)), Ho, P. J. (Chief Investigator (CI)) & McCaughan, G. (Chief Investigator (CI))

  1/08/24 → 31/07/28

  Project: Research

• Establishing blood-based liquid biopsies for early detection of high-risk multiple myeloma

  Bingham, N., Mithraprabhu, S., Spencer, A. & Reynolds, J.

  1/07/24 → 1/07/25

  Project: Research

• Defining the circulating genome of high-risk plasma cell disorders to improve risk stratification and clinical management

  Mithraprabhu, S. (Primary Chief Investigator (PCI)), Khong, T. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Murray, D. (Chief Investigator (CI)), Shah, J. (Chief Investigator (CI)), Wellard, C. (Chief Investigator (CI)), Spencer, A. (Associate Investigator (AI)), Ross, J. (Associate Investigator (AI)), Perkins, A. (Associate Investigator (AI)), Marks, A. (Associate Investigator (AI)), Beer, H. (Associate Investigator (AI)) & Henderson, M. (Associate Investigator (AI))

  1/04/24 → 31/12/26

  Project: Research

• AAT-APP Trial: A RCT of alcohol approach-avoidance training to reduce heavy drinking in people with alcohol use disorders

  Manning, V. (Primary Chief Investigator (PCI)), Verdejo-Garcia, A. (Chief Investigator (CI)), Lubman, D. (Chief Investigator (CI)), Staiger, P. K. (Chief Investigator (CI)), Garfield, J. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), de New, S. (Chief Investigator (CI)), Wiers, R. (Chief Investigator (CI)) & Roxburgh, A. (Associate Investigator (AI))

  1/01/23 → 30/06/26

  Project: Research

• More efficient delivery of high-cost standard-of-care therapies in relapsed multiple myeloma using real-time feedback of patient-reported outcome measures: the MY-PROMPT-2 trial

  Spencer, A. (Primary Chief Investigator (PCI)), Rutherford, C. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Ho, P. J. (Chief Investigator (CI)), McQuilten, Z. (Chief Investigator (CI)), Moore, E. (Chief Investigator (CI)), King, T. (Chief Investigator (CI)), Wood, E. (Chief Investigator (CI)), Harrison, S. J. (Chief Investigator (CI)) & Irving, A. (Chief Investigator (CI))

  Department of Health and Aged Care (Australia)

  1/02/22 → 31/01/27

  Project: Research

• INTERCEPT (Investigating Novel Therapy to target Early Relapse and Clonal Evolution as Pre-emptive Therapy in AML): a multi-arm, precision-based, recursive, platform trial

  Wei, A. (Primary Chief Investigator (PCI)), DiNardo, C. (Chief Investigator (CI)), Roberts, A. W. (Chief Investigator (CI)), Daver, N. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Blombery, P. (Chief Investigator (CI)), Marlton, P. (Chief Investigator (CI)) & Curtis, D. (Chief Investigator (CI))

  1/07/21 → 30/06/26

  Project: Research

• Preventing infections in patients with blood cancer through evidence-based use of immunoglobulin or alternatives: The RATIONALISE trial

  Wood, E. (Primary Chief Investigator (PCI)), McQuilten, Z. (Chief Investigator (CI)), Morrissey, O. (Chief Investigator (CI)), Trotman, J. (Chief Investigator (CI)), Spencer, A. (Chief Investigator (CI)), Opat, S. (Chief Investigator (CI)), Fanning, L. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Paterson, D. L. (Chief Investigator (CI)) & Mulligan, S. P. (Chief Investigator (CI))

  1/07/21 → 30/06/26

  Project: Research

• An ALLG single arm phase II study to evaluate the efficacy of asciminib in newly diagnosed patients with chronic phase chronic myeloid leukaemia

  Reynolds, J. (Primary Chief Investigator (PCI))

  1/12/20 → 1/12/25

  Project: Research

• Frailty stratified, randomised controlled Bayesian adaptive trial of bortezomib versus lenalidomide in transplant-ineligible myeloma – the FRAIL-M study

  Spencer, A. (Primary Chief Investigator (PCI)), McQuilten, Z. (Chief Investigator (CI)), Wood, E. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Quach, H. (Chief Investigator (CI)), De Abreu Lourenco, R. (Chief Investigator (CI)), King, M. (Chief Investigator (CI)), Mollee, P. N. (Chief Investigator (CI)), Hubbard, R. E. (Chief Investigator (CI)) & Le, K. (Chief Investigator (CI))

  Department of Health and Aged Care (Australia)

  1/12/20 → 30/09/25

  Project: Research

• Precision Medicine for Chronic Myelomonocytic Leukaemia: Phase II Trial Studying the Efficacy of Lenzilumab or High Dose Ascorbate plus Azacitidine Based on Molecular Profiling Compared to Risk-matched Historical Cohort.

  Hughes, T. P. (Primary Chief Investigator (PCI)), Hiwase, D. K. (Chief Investigator (CI)), Ross, D. M. (Chief Investigator (CI)) & Reynolds, J. (Chief Investigator (CI))

  1/06/20 → 31/05/25

  Project: Research

• Addressing Australia’s national transfusion research priorities

  Wood, E. (Primary Chief Investigator (PCI)), McQuilten, Z. (Chief Investigator (CI)), Cameron, P. (Chief Investigator (CI)), Cooper, J. (Chief Investigator (CI)), Reade, M. (Chief Investigator (CI)), Higgins, L. (Chief Investigator (CI)), Trotman, J. (Chief Investigator (CI)), Stanworth, S. J. (Chief Investigator (CI)), Bielby, L. (Chief Investigator (CI)), Coiera, E. (Associate Investigator (AI)), Reynolds, J. (Associate Investigator (AI)), Mo, A. G. Y. (Associate Investigator (AI)), Flint, A. (Associate Investigator (AI)), Sanderson, B. J. (Associate Investigator (AI)), Sparrow, R. (Associate Investigator (AI)), Harris, A. (Associate Investigator (AI)) & French, C. J. (Associate Investigator (AI))

  1/01/20 → 31/12/25

  Project: Research

• Finished

  An ALLG Phase 2 study to Investigate Novel Triplets to Extend Remission with Venetoclax in Elderly (INTERVENE) Acute Myeloid Leukaemia

  Reynolds, J.

  1/12/20 → 1/12/24

  Project: Research

• A randomised controlled trial of telephone-delivered psychological treatment to reduce methamphetamine use

  Lubman, D. (Primary Chief Investigator (PCI)), Manning, V. (Chief Investigator (CI)), Hall, K. (Chief Investigator (CI)), Arunogiri, S. (Chief Investigator (CI)), Grigg, J. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)) & Harris, A. (Chief Investigator (CI))

  1/01/20 → 31/12/23

  Project: Research

• A phase 2 study of venetoclax in combination with low-dose cytarabine in relapsing acute myeloid leukemia.

  Wei, A. (Primary Chief Investigator (PCI)), Tiong, I. S. (Chief Investigator (CI)), Reynolds, J. (Associate Investigator (AI)) & Kennedy, N. (Chief Investigator (CI))

  22/09/19 → 31/12/24

  Project: Research

• Transforming the treatment landscape in elderly Acute Myeloid Leukaemia (AML)

  Wei, A. (Primary Chief Investigator (PCI)), Bohlander, S. K. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)) & Levis, M. (Chief Investigator (CI))

  1/05/19 → 31/12/22

  Project: Research

• Novel Venetoclax Combinations To Improve Outcomes In Unfit Older Patients With Acute Myeloid Leukaemia

  Wei, A. (Primary Chief Investigator (PCI)), Reynolds, J. (Chief Investigator (CI)), Ritchie, D. S. (Chief Investigator (CI)), Ananda-Rajah, M. (Chief Investigator (CI)), Liew, D. (Associate Investigator (AI)) & Ivey, A. (Associate Investigator (AI))

  1/04/19 → 31/03/24

  Project: Research

• A registry-linked national platform trial to improve precision-based outcomes using novel therapies in acute myeloid leukaemia (AML)

  Wei, A. (Primary Chief Investigator (PCI)), Dawson, M. A. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Bohlander, S. K. (Chief Investigator (CI)), Ivey, A. (Chief Investigator (CI)), Ekert, P. (Associate Investigator (AI)), Marlton, P. (Associate Investigator (AI)) & Blombery, P. (Associate Investigator (AI))

  13/06/18 → 31/12/23

  Project: Research

• Interactive attention training technology to enhance cognitive skills in early life

  Cornish, K. (Primary Chief Investigator (PCI)), Anderson, V. (Chief Investigator (CI)), Harcourt, J. (Chief Investigator (CI)), Catroppa, C. (Chief Investigator (CI)), Kirk, H. (Chief Investigator (CI)), McIntosh, B. (Chief Investigator (CI)) & Reynolds, J. (Chief Investigator (CI))

  1/04/18 → 31/03/22

  Project: Research

• Chronic Myeloid Leukaemia: Changing the treatment paradigm

  Hughes, T. P. (Primary Chief Investigator (PCI)), Yong, A. (Chief Investigator (CI)), Branford, S. (Chief Investigator (CI)), White, D. L. (Chief Investigator (CI)), Ross, D. M. (Chief Investigator (CI)) & Reynolds, J. (Chief Investigator (CI))

  1/01/18 → 31/12/21

  Project: Research

• Analysis of circulating tumour DNA for mutational characterisation and tracking disease progression in multiple myeloma

  Spencer, A., Mithraprabhu, S., Powell, D., Reynolds, J. & Ivey, A.

  1/01/18 → 31/12/21

  Project: Research

• The International Acute Myeloid Leukaemia Platform Consortium (IAPC)

  Wei, A. (Primary Chief Investigator (PCI)), Roberts, A. W. (Chief Investigator (CI)), Dawson, M. A. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Ritchie, D. S. (Chief Investigator (CI)), Ekert, P. (Chief Investigator (CI)) & Ivey, A. (Chief Investigator (CI))

  13/04/17 → 12/04/22

  Project: Research

• The R2C Program: A randomised controlled trial of a telephone-based intervention for alcohol misuse

  Lubman, D. (Primary Chief Investigator (PCI)), Baker, A. L. (Chief Investigator (CI)), Staiger, P. K. (Chief Investigator (CI)), Best, D. (Chief Investigator (CI)), Manning, V. (Chief Investigator (CI)), Hall, K. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Harris, A. (Chief Investigator (CI)) & Grigg, J. (Project Manager)

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/17 → 31/12/20

  Project: Research

• Augmented immune targeting of a myeloma-specific tumour antigen.

  Shortt, J. (Primary Chief Investigator (PCI)), Spencer, A. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Johnstone, R. W. (Chief Investigator (CI)), Quach, H. (Chief Investigator (CI)), Grigoriadis, G. (Chief Investigator (CI)), Kalff, A. (Chief Investigator (CI)), Khong, T. (Chief Investigator (CI)), Walker, P. A. (Associate Investigator (AI)) & Powell, D. (Associate Investigator (AI))

  15/12/16 → 31/12/18

  Project: Research

• Developing and evaluating a new cost effective health and wellbeing model of care for children with a disability and their carers

  Gibbs, L. (Primary Chief Investigator (PCI)), Reddihough, D. S. (Chief Investigator (CI)), Carter, R. C. (Chief Investigator (CI)), Williams, K. (Chief Investigator (CI)), Reynolds, J. (Chief Investigator (CI)), Tracy, J. (Chief Investigator (CI)) & McDonald, R. (Chief Investigator (CI))

  27/10/14 → 26/10/19

  Project: Research